BIO-key International （BKYI.US）Stock price
The stock surged as much as 117.42% and is now up 84.33% at $1.17, with trading volume reaching $387 million.
Over the past three months, two analysts have issued ratings for BIO-key International.
The average target price forecast for BIO-key International stock is $1.50, with a high of $2.00 and a low of $1.00.
The most recent analyst rating on BKYI stock is a Hold with a $0.50 price target.
Average Trading Volume: 4,452,813
Technical Sentiment Signal: Sell
Current Market Cap: $4.63M
BIO-key International （BKYI） News
BIO-key International （BKYI） said Friday it secured a “significant new deployment with a major defense-sector security organisation” in the Middle East.
The customer “requested that their identity not be disclosed for security reasons,” the company said.
BIO-key Granted Extension by Nasdaq for Compliance
On May 9, 2025, BIO-key International received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. Despite not regaining compliance by November 6, 2025, Nasdaq granted the company an additional 180 days, until May 4, 2026, to meet the requirement. The company plans to monitor its stock price and may implement a reverse stock split to maintain its Nasdaq listing.
Spark’s Take on BKYI Stock
According to Spark, TipRanks’ AI Analyst, BKYI is a Neutral.
BIO-key International’s overall stock score is primarily impacted by its challenging financial performance and valuation concerns, with ongoing losses and negative cash flow. Despite positive developments in revenue growth and strategic contracts highlighted in the earnings call, the stock’s technical indicators suggest a bearish trend.
BIO-key International, Inc. （BKYI） Description
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company’s solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.